Friederike Held

473 total citations
9 papers, 165 citations indexed

About

Friederike Held is a scholar working on Pathology and Forensic Medicine, Neurology and Neurology. According to data from OpenAlex, Friederike Held has authored 9 papers receiving a total of 165 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 3 papers in Neurology. Recurrent topics in Friederike Held's work include Multiple Sclerosis Research Studies (6 papers), Peripheral Neuropathies and Disorders (2 papers) and Alzheimer's disease research and treatments (2 papers). Friederike Held is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Peripheral Neuropathies and Disorders (2 papers) and Alzheimer's disease research and treatments (2 papers). Friederike Held collaborates with scholars based in Germany, United Kingdom and Austria. Friederike Held's co-authors include Achim Berthele, Bernhard Hemmer, Stefanie Schreiber, Hans‐Jochen Heinze, Roxana O. Carare, Cornelia Garz, Sudhakar Reddy Kalluri, Markus Reindl, Matthew MacGregor Sharp and Daniel Pirici and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Neurology and Journal of Alzheimer s Disease.

In The Last Decade

Friederike Held

8 papers receiving 163 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Friederike Held Germany 6 74 63 47 37 20 9 165
Carlotta Chiavazza Italy 5 105 1.4× 84 1.3× 21 0.4× 28 0.8× 15 0.8× 5 180
Mattia Fonderico Italy 10 50 0.7× 124 2.0× 33 0.7× 12 0.3× 30 1.5× 13 196
Aram Zabeti United States 9 102 1.4× 103 1.6× 21 0.4× 24 0.6× 34 1.7× 22 196
Arabella Buchmann Austria 8 68 0.9× 69 1.1× 13 0.3× 25 0.7× 34 1.7× 14 180
Elio Prestipino Italy 9 60 0.8× 137 2.2× 17 0.4× 10 0.3× 16 0.8× 15 196
Nicole Ziliotto Italy 11 52 0.7× 63 1.0× 37 0.8× 22 0.6× 80 4.0× 24 246
Mirjam Korporal‐Kuhnke Germany 9 75 1.0× 123 2.0× 23 0.5× 13 0.4× 30 1.5× 11 193
Hirohiko Ono Japan 6 65 0.9× 78 1.2× 26 0.6× 6 0.2× 23 1.1× 13 150
Angelo Bellinvia Italy 8 52 0.7× 147 2.3× 16 0.3× 12 0.3× 15 0.8× 16 191
Ryo Tamaki Japan 7 51 0.7× 54 0.9× 95 2.0× 21 0.6× 94 4.7× 24 314

Countries citing papers authored by Friederike Held

Since Specialization
Citations

This map shows the geographic impact of Friederike Held's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friederike Held with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friederike Held more than expected).

Fields of papers citing papers by Friederike Held

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friederike Held. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friederike Held. The network helps show where Friederike Held may publish in the future.

Co-authorship network of co-authors of Friederike Held

This figure shows the co-authorship network connecting the top 25 collaborators of Friederike Held. A scholar is included among the top collaborators of Friederike Held based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friederike Held. Friederike Held is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Held, Friederike, et al.. (2024). Proteomics Reveals Age as Major Modifier of Inflammatory CSF Signatures in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 12(1). e200322–e200322. 4 indexed citations
3.
Jacobs, Benjamin M., Christiane Gasperi, Sudhakar Reddy Kalluri, et al.. (2024). Single-cell analysis of cerebrospinal fluid reveals common features of neuroinflammation. Cell Reports Medicine. 6(1). 101733–101733. 1 indexed citations
4.
Berthele, Achim, et al.. (2023). The impact of disease-modifying therapies on immunoglobulin blood levels in patients with multiple sclerosis: a retrospective cross-sectional study. Therapeutic Advances in Neurological Disorders. 16. 4223443749–4223443749. 6 indexed citations
5.
Held, Friederike, et al.. (2021). Drug Treatment of Neuromyelitis Optica Spectrum Disorders: Out with the Old, in with the New?. SHILAP Revista de lepidopterología. Volume 10. 87–101. 19 indexed citations
6.
Held, Friederike, et al.. (2021). Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(2). 3080385967–3080385967. 31 indexed citations
7.
Vandebergh, Marijne, Till F. M. Andlauer, Yuan Zhou, et al.. (2021). Genetic Variation in WNT9B Increases Relapse Hazard in Multiple Sclerosis. Annals of Neurology. 89(5). 884–894. 16 indexed citations
8.
Held, Friederike, Alan Morris, Daniel Pirici, et al.. (2017). Vascular basement membrane alterations and β-amyloid accumulations in an animal model of cerebral small vessel disease. Clinical Science. 131(10). 1001–1013. 43 indexed citations
9.
Schreiber, Stefanie, Benjamin Drukarch, Cornelia Garz, et al.. (2014). Interplay Between Age, Cerebral Small Vessel Disease, Parenchymal Amyloid-β, and Tau Pathology: Longitudinal Studies in Hypertensive Stroke-Prone Rats. Journal of Alzheimer s Disease. 42(s3). S205–S215. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026